Literature DB >> 19384675

Digoxin for the treatment of chronic and acute heart failure syndromes.

Mihai Gheorghiade1, Matthew E Harinstein, Gerasimos S Filippatos.   

Abstract

Digitalis preparations have been used for centuries. Digoxin is an agent that is readily available, can be administered acutely and long-term, intravenously or orally, is safe and may be beneficial in both acute and chronic heart failure (HF). It may be an ideal drug for the treatment of acute heart failure syndromes and warrants further investigation in large clinical trials. The role of digoxin in acute and chronic HF was discussed at the 2008 European Society of Cardiology Working Group on Acute Cardiac Care Meeting held in Versailles, France from 25-28 October 2008. This report represents a summary of the presentation at this meeting.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384675     DOI: 10.1080/17482940902883246

Source DB:  PubMed          Journal:  Acute Card Care        ISSN: 1748-2941


  9 in total

1.  Effect of cardiovascular drug classes on all-cause mortality among atrial fibrillation patients treated in primary care in Sweden: a cohort study.

Authors:  Per Wändell; Axel C Carlsson; Kristina Sundquist; Sven-Erik Johansson; Jan Sundquist
Journal:  Eur J Clin Pharmacol       Date:  2012-09-19       Impact factor: 2.953

2.  Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.

Authors:  Jeffrey M Testani; Meredith A Brisco; W H Wilson Tang; Stephen E Kimmel; Anjali Tiku-Owens; Paul R Forfia; Steven G Coca
Journal:  J Card Fail       Date:  2013-05       Impact factor: 5.712

3.  Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010.

Authors:  Isaac See; Nadine Shehab; Scott R Kegler; S Raja Laskar; Daniel S Budnitz
Journal:  Circ Heart Fail       Date:  2013-12-03       Impact factor: 8.790

4.  Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses.

Authors:  Per Wändell; Axel C Carlsson; Jan Sundquist; Sven-Erik Johansson; Matteo Bottai; Kristina Sundquist
Journal:  Diabetol Metab Syndr       Date:  2014-01-07       Impact factor: 3.320

Review 5.  Rethinking Heart Failure.

Authors:  Hauke Fürstenwerth
Journal:  Cardiol Res       Date:  2012-11-20

6.  In vitro and in vivo antileishmanial activity of β-acetyl-digitoxin, a cardenolide of Digitalis lanata potentially useful to treat visceral leishmaniasis.

Authors:  Camila S Freitas; Daniela P Lage; João A Oliveira-da-Silva; Rafaella R Costa; Débora V C Mendonça; Vívian T Martins; Thiago A R Reis; Luciana M R Antinarelli; Amanda S Machado; Grasiele S V Tavares; Fernanda F Ramos; Rory C F Brito; Fernanda Ludolf; Miguel A Chávez-Fumagalli; Bruno M Roatt; Gabriela S Ramos; Jennifer Munkert; Flaviano M Ottoni; Priscilla R V Campana; Mariana C Duarte; Denise U Gonçalves; Elaine S Coimbra; Fernão C Braga; Rodrigo M Pádua; Eduardo A F Coelho
Journal:  Parasite       Date:  2021-04-14       Impact factor: 3.000

7.  Development of Indirect Competitive Enzyme-Linked Immunosorbent Assay and Lateral-Flow Immunochromatographic Strip for the Detection of Digoxin in Human Blood.

Authors:  Fanqian Ling; Liqiang Liu; Hua Kuang; Gang Cui; Chuanlai Xu
Journal:  ACS Omega       Date:  2020-01-13

8.  Digitoxigenin presents an effective and selective antileishmanial action against Leishmania infantum and is a potential therapeutic agent for visceral leishmaniasis.

Authors:  Camila S Freitas; João A Oliveira-da-Silva; Daniela P Lage; Rafaella R Costa; Débora V C Mendonça; Vívian T Martins; Thiago A R Reis; Luciana M R Antinarelli; Amanda S Machado; Grasiele S V Tavares; Fernanda F Ramos; Vinicio T S Coelho; Rory C F Brito; Fernanda Ludolf; Miguel A Chávez-Fumagalli; Bruno M Roatt; Gabriela S Ramos; Jennifer Munkert; Flaviano M Ottoni; Priscilla R V Campana; Maria V Humbert; Elaine S Coimbra; Fernão C Braga; Rodrigo M Pádua; Eduardo A F Coelho
Journal:  Parasitol Res       Date:  2020-11-16       Impact factor: 2.289

9.  A 5 Years Assessment of Patients with Acute Digoxin Poisoning: A Toxicoepidemiology Study in Iran.

Authors:  Mitra Rahimi; Arezou Mahdavinejad; Shahin Shadnia; Ali Saffaei
Journal:  Heart Views       Date:  2022-02-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.